Cooley Advises Celladon on its Initial Public Offering

Cooley LLP announced today that it advised Celladon Corporation on its initial public offering. Celladon is a clinical-stage biotechnology company that targets SERCA enzymes to develop novel therapies for diseases with tremendous unmet medical needs. The company now trades on the NSADAQ Global Stock Market under the symbol, “CLDN.”

More >>

Tags:  Cooley LLP

Latham & Watkins Advises Cadence Pharmaceuticals in its Acquisition by Mallinckrodt plc

Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. have announced a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. The announced transaction price was $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis. The deal is subject to customary terms and conditions and the parties expect the transaction to close in mid- to late-March. More >>

Tags:  Latham & Watkins LLP

Simpson Thacher Represents the Initial Purchasers in Micron Technology, Inc.’s $600 Million Senior Notes Offering

The Firm recently represented the initial purchasers, led by Morgan Stanley, Goldman, Sachs & Co., and Credit Suisse, in connection with Micron Technology, Inc.’s offering of $600 million aggregate principal amount of 5.875% Senior Notes due 2022. The notes were offered in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended.

More >>

Tags:  Simpson Thacher & Bartlett LLP

Shearman & Sterling Advises on American Tower Corporation’s $750 Million Senior Notes Offering

Shearman & Sterling represented Barclays Capital Inc., Goldman, Sachs & Co., RBC Capital Markets, LLC, RBS Securities Inc. and TD Securities (USA) LLC as representatives of the several underwriters in connection with an offering of $250 million aggregate principal amount of 3.40% Senior Notes due 2019 and $500 million aggregate principal amount of 5.00% Senior Notes due 2024 by American Tower Corporation. The offering was a reopening of American Tower Corporation’s $750 million 3.40% Senior Notes due 2019 and $250 million 5.00% Senior Notes due 2024 issued on August 19, 2013. American Tower Corporation intends to use the proceeds to repay existing indebtedness it incurred under credit facilities, which have been used to fund recent acquisitions.

More >>

Tags:  Shearman & Sterling LLP

Simpson Thacher Represents CHC Helicopter S.A. in Refinancing

Simpson Thacher recently represented CHC Helicopter S.A. (“CHC Helicopter”), a portfolio company of First Reserve Corporation, in connection with its refinancing of a $375 million super-senior secured revolving credit facility.  The revolving credit facility is guaranteed by certain of CHC Helicopter’s parents and subsidiaries located in Europe, Australia and North America. More >>

Tags:  Simpson Thacher & Bartlett LLP